pioglitazone has been researched along with dinoprost in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hiraoka, M; Toriumi, Y; Watanabe, M; Yoshida, M | 1 |
Azuma, J; Fujio, Y; Fujitsu, J; Kasayama, S; Kim, J; Maeda, M; Sumita, C; Yamamoto, I | 1 |
Everett, CJ; King, DE; Player, M | 1 |
Hou, WK; Huang, QX; Li, MZ; Lin, P; Liu, Q; Song, J; Wang, K; Wang, Q; Xu, H; Yu, S; Zhang, L; Zhang, Y | 1 |
2 trial(s) available for pioglitazone and dinoprost
Article | Year |
---|---|
The impact of pioglitazone on ADMA and oxidative stress markers in patients with type 2 diabetes.
Topics: Academic Medical Centers; Arginine; Biomarkers; Cross-Over Studies; Diabetes Mellitus, Type 2; Dinoprost; F2-Isoprostanes; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Nitrates; Nitrites; Oxidative Stress; Pioglitazone; Prospective Studies; South Carolina; Thiazolidinediones; Time Factors; Treatment Outcome | 2012 |
Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients.
Topics: Apelin; Blood Glucose; Body Mass Index; Chemokines; Diabetes Mellitus, Type 2; Dinoprost; Humans; Hypoglycemic Agents; Inflammation; Intercellular Signaling Peptides and Proteins; Metformin; Pioglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2012 |
2 other study(ies) available for pioglitazone and dinoprost
Article | Year |
---|---|
Pioglitazone reduces monocyte adhesion to vascular endothelium under flow by modulating RhoA GTPase and focal adhesion kinase.
Topics: Actins; Cell Adhesion; Cells, Cultured; Dinoprost; Endothelium, Vascular; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; GTP Phosphohydrolases; Humans; Integrins; Monocytes; Phosphorylation; Pioglitazone; Protein-Tyrosine Kinases; rhoA GTP-Binding Protein; Signal Transduction; Thiazolidinediones; U937 Cells; Umbilical Veins | 2003 |
Pioglitazone induces plasma platelet activating factor-acetylhydrolase and inhibits platelet activating factor-mediated cytoskeletal reorganization in macrophage.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Cell Line; Cytoskeleton; Dinoprost; Enzyme Induction; Humans; Macrophages; Pioglitazone; Platelet Activating Factor; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Transcription Factors | 2004 |